Laura Sutcliffe
Stock Analyst at Citi
(2.76)
# 2,794
Out of 4,504 analysts
489
Total ratings
52%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $39.00 → $42.00 | $41.95 | +0.12% | 15 | Jul 10, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $32.00 | $16.27 | +96.68% | 33 | Jul 7, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $36.00 → $33.50 | $31.27 | +7.13% | 15 | Jul 6, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $245.00 → $240.00 | $197.07 | +21.78% | 6 | Jul 2, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $110.00 | $122.89 | -10.49% | 36 | Jun 30, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $21.50 → $19.00 | $21.24 | -10.55% | 15 | Jun 23, 2026 | |
| RMD ResMed | Rated: Buy | $340 → $270 | $203.87 | +32.44% | 13 | Jun 15, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $48.00 → $38.00 | $30.03 | +26.54% | 19 | Jun 15, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Hold | n/a | $40.25 | - | 6 | May 27, 2026 | |
| ASX: COH Cochlear Limited | Downgraded: Sell | $210.00 → $95.00 | $121.62 | -21.89% | 15 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $31.28 | $22.15 | +41.21% | 4 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €40.00 → €34.00 | $26.32 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 86.00 → CHF 84.00 | $124.28 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.87 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | $76.23 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,850p → 1,820p | $1,961.50 | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €87.00 | $250.17 | n/a | 16 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,880 → kr 2,600 | $1,888.98 | n/a | 16 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $29.00 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $154.05 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $877.62 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $88 | $30.27 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €108.00 | $139.70 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $43.50 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.78 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $303 → $300 | $49.48 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,188.58 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $57.58 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $129.83 | n/a | 14 | Oct 18, 2017 |
Ramsay Health Care Limited
Jul 10, 2026
Maintained: Hold
Price Target: $39.00 → $42.00
Current: $41.95
Upside: +0.12%
Telix Pharmaceuticals Limited
Jul 7, 2026
Maintained: Buy
Price Target: $32.00
Current: $16.27
Upside: +96.68%
Ansell Limited
Jul 6, 2026
Maintained: Hold
Price Target: $36.00 → $33.50
Current: $31.27
Upside: +7.13%
Pro Medicus Limited
Jul 2, 2026
Maintained: Buy
Price Target: $245.00 → $240.00
Current: $197.07
Upside: +21.78%
CSL Limited
Jun 30, 2026
Maintained: Hold
Price Target: $110.00
Current: $122.89
Upside: -10.49%
Sonic Healthcare Limited
Jun 23, 2026
Maintained: Hold
Price Target: $21.50 → $19.00
Current: $21.24
Upside: -10.55%
ResMed
Jun 15, 2026
Rated: Buy
Price Target: $340 → $270
Current: $203.87
Upside: +32.44%
ResMed Inc.
Jun 15, 2026
Maintained: Buy
Price Target: $48.00 → $38.00
Current: $30.03
Upside: +26.54%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Hold
Price Target: n/a
Current: $40.25
Upside: -
Cochlear Limited
Apr 22, 2026
Downgraded: Sell
Price Target: $210.00 → $95.00
Current: $121.62
Upside: -21.89%
Feb 25, 2026
Upgraded: Buy
Price Target: $31.28
Current: $22.15
Upside: +41.21%
May 7, 2024
Maintained: Hold
Price Target: €40.00 → €34.00
Current: $26.32
Upside: n/a
Dec 14, 2022
Maintained: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: $124.28
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.87
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: $76.23
Upside: n/a
Aug 8, 2022
Maintained: Hold
Price Target: 1,850p → 1,820p
Current: $1,961.50
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: €95.00 → €87.00
Current: $250.17
Upside: n/a
May 20, 2022
Maintained: Buy
Price Target: kr 2,880 → kr 2,600
Current: $1,888.98
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $29.00
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $154.05
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $877.62
Upside: n/a
Apr 12, 2021
Maintained: Hold
Price Target: $86 → $88
Current: $30.27
Upside: n/a
Feb 28, 2020
Maintained: Hold
Price Target: €108.00
Current: $139.70
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $43.50
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $52.78
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: $303 → $300
Current: $49.48
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,188.58
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $57.58
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $129.83
Upside: n/a